OUR INSIGHTS

Our insights

Stay ahead of the game

Hiring Strategy & Workforce Planning
How pharma and medtech employers are preparing for 2027
1 Sep 2026 | Words by Star People BD Team

Workforce planning for 2027 has already started for many industry commercial leaders. Not because budgets have been signed off, because vacancies exist, or because organisations are looking to hire immediately.

It’s down to the face that in-demand skills required to deliver future growth are becoming harder to secure.

As launch timelines tighten, systems become more complex and commercial expectations continue to rise, workforce planning is increasingly intertwined with business planning. The conversation is shifting from headcount to capability. Employers are asking not only who they need, but what skills, expertise and leadership will be required to achieve future objectives.


Commercial capability remains firmly on the agenda

One of the strongest signals we’re seeing in the market is continued demand for commercial talent. UK life sciences sales and marketing vacancies increased by 18.7% year-on-year during 2025, with demand increasingly concentrated around strategic commercial roles, account management and customer-facing leadership positions.

At the same time, commercial hiring across Europe remains resilient, particularly for professionals capable of combining commercial expertise with digital fluency, stakeholder engagement and healthcare system understanding.

What’s changing is the type of talent organisations are prioritising.

Commercial teams need to deliver more value from fewer interactions, launches require stronger account engagement and customer journeys are increasingly multi-channel. Success relies less on headcount alone and more on capabilities that influence adoption, engagement and performance.

Conversations are centring around what commercial capability will be needed in 2027 rather than simply what vacancies exist today.


Market access is becoming a growth-enabling capability

Market access continues to move higher up the strategic agenda.

As greater emphasis is placed on value, affordability, evidence generation and outcomes-focused decision-making by healthcare, pharma and medtech need professionals who can successfully navigate increasingly complex payer and stakeholder environments. The NHS 10-Year Health Plan and wider life sciences strategy continue to reinforce the importance of innovation adoption and demonstrating value across healthcare systems.

The challenge is that the pool of experienced market access professionals remains relatively small. Many are well-established, highly successful and not actively seeking new opportunities. This means that organisations waiting until a vacancy becomes urgent often find themselves competing for the same individuals at the same time.

The businesses planning most effectively are already mapping future market access capability requirements and building relationships ahead of demand.


Medical affairs is increasingly strategic

Medical affairs has evolved significantly over the last decade. What was once viewed primarily as a scientific support function is now closely linked to evidence generation, external engagement, real-world data strategies and broader organisational success.

The UK recorded 578 industry clinical trials during 2024, up on previous years and reflecting continued investment in research, evidence development and scientific innovation. This is contributing to sustained demand for experienced medical affairs professionals capable of supporting scientific exchange, healthcare engagement and evidence-led decision making.

Many organisations are no longer treating medical affairs hiring as a reactive process. Instead, they are considering how future scientific capability will support upcoming launches, stakeholder engagement strategies and evidence generation programmes.


Leadership succession is moving up the agenda

One of the most common themes emerging from conversations with commercial and HR leaders is succession planning.

Many organisations can already identify where future risk may exist:

  • Commercial leadership positions
  • Regional business leaders
  • Market access leadership roles
  • Medical affairs leadership positions
  • Specialist subject matter experts

The challenge is that replacing leadership capability takes considerably longer than replacing operational capacity.

Forward-thinking organisations are therefore taking a more proactive approach to leadership planning, talent mapping and succession strategies. Rather than reacting to leadership departures when they occur, they are building visibility of future capability requirements now.

For many businesses, leadership succession has become a business continuity discussion rather than a recruitment discussion.


Why some organisations have already started hiring

Some organisations have already started recruiting for capabilities they won’t fully require until 2027. This isn’t necessarily because they have more budget available. It’s because they understand that future workforce requirements are becoming more difficult to predict, while specialist talent remains highly competitive.

These organisations are hiring ahead of:

  • Product launches
  • Commercial transformation programmes
  • Future market access requirements
  • Leadership transitions
  • Planned expansion into new therapy areas

The earlier employers engage with the talent market, the more options they give themselves – accessing wider talent pools, reducing pressure on future hiring timelines and avoiding competing reactively when demand peaks.


Looking beyond traditional hiring models

Not every future capability challenge is solved through permanent hiring alone. Organisations may wish to combine headcount with outsourced commercial teams, vacancy management solutions and other flexible resource models.

This approach allows businesses to:

  • Maintain commercial momentum during hiring processes
  • Support launches more effectively
  • Access specialist expertise rapidly
  • Protect customer engagement
  • Reduce the impact of capability gaps

Rather than choosing between permanent recruitment and outsourced support, many organisations are using both strategically to create a more resilient workforce model. This aligns with wider life sciences workforce trends, where employers are increasingly balancing permanent and contingent talent to improve agility and access specialist expertise.


Planning for 2027?

Through permanent headcount recruitment, outsourced teams, vacancy management and workforce planning, we help pharma and medtech organisations secure the talent and capability required to achieve future objectives.

Connect with Danny and the team for a confidential discussion about recruitment, outsourcing and workforce planning for 2027 and beyond.


Sources

Looking to recruit star people or want some insight into your next career move?
Explore our strategic people solutions >
Upload my CV >

Need some insight? Get in touch